Click for best price
Respiratory Disorders Drugs Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Respiratory Disorders Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Disorders Drugs. This report contains market size and forecasts of Respiratory Disorders Drugs in global, including the following market information:
Global Respiratory Disorders Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Respiratory Disorders Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Oral Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Respiratory Disorders Drugs include Novartis, Sanofi, Teva Pharmaceutical, Merck & Co., Sumitomo Dainippon Pharma, Mylan, AstraZeneca, Boehringer Ingelheim International and Vertex Pharmaceuticals Incorporated, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Respiratory Disorders Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Respiratory Disorders Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Respiratory Disorders Drugs Market Segment Percentages, by Type, 2022 (%)
Oral
Nasal
Injectable
Global Respiratory Disorders Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Respiratory Disorders Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Retail Pharmacy
Global Respiratory Disorders Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Respiratory Disorders Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Respiratory Disorders Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Respiratory Disorders Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Sanofi
Teva Pharmaceutical
Merck & Co.
Sumitomo Dainippon Pharma
Mylan
AstraZeneca
Boehringer Ingelheim International
Vertex Pharmaceuticals Incorporated
Roche
GlaxoSmithKline
Outline of Major Chapters:
Chapter 1: Introduces the definition of Respiratory Disorders Drugs, market overview.
Chapter 2: Global Respiratory Disorders Drugs market size in revenue.
Chapter 3: Detailed analysis of Respiratory Disorders Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Respiratory Disorders Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Respiratory Disorders Drugs Market Professional Survey, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Respiratory Disorders Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Respiratory Disorders Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Respiratory Disorders Drugs Overall Market Size
2.1 Global Respiratory Disorders Drugs Market Size: 2022 VS 2029
2.2 Global Respiratory Disorders Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Respiratory Disorders Drugs Players in Global Market
3.2 Top Global Respiratory Disorders Drugs Companies Ranked by Revenue
3.3 Global Respiratory Disorders Drugs Revenue by Companies
3.4 Top 3 and Top 5 Respiratory Disorders Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Respiratory Disorders Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Respiratory Disorders Drugs Players in Global Market
3.6.1 List of Global Tier 1 Respiratory Disorders Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Respiratory Disorders Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Respiratory Disorders Drugs Market Size Markets, 2022 & 2029
4.1.2 Oral
4.1.3 Nasal
4.1.4 Injectable
4.2 By Type - Global Respiratory Disorders Drugs Revenue & Forecasts
4.2.1 By Type - Global Respiratory Disorders Drugs Revenue, 2018-2023
4.2.2 By Type - Global Respiratory Disorders Drugs Revenue, 2024-2029
4.2.3 By Type - Global Respiratory Disorders Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Respiratory Disorders Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.2 By Application - Global Respiratory Disorders Drugs Revenue & Forecasts
5.2.1 By Application - Global Respiratory Disorders Drugs Revenue, 2018-2023
5.2.2 By Application - Global Respiratory Disorders Drugs Revenue, 2024-2029
5.2.3 By Application - Global Respiratory Disorders Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Respiratory Disorders Drugs Market Size, 2022 & 2029
6.2 By Region - Global Respiratory Disorders Drugs Revenue & Forecasts
6.2.1 By Region - Global Respiratory Disorders Drugs Revenue, 2018-2023
6.2.2 By Region - Global Respiratory Disorders Drugs Revenue, 2024-2029
6.2.3 By Region - Global Respiratory Disorders Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Respiratory Disorders Drugs Revenue, 2018-2029
6.3.2 US Respiratory Disorders Drugs Market Size, 2018-2029
6.3.3 Canada Respiratory Disorders Drugs Market Size, 2018-2029
6.3.4 Mexico Respiratory Disorders Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Respiratory Disorders Drugs Revenue, 2018-2029
6.4.2 Germany Respiratory Disorders Drugs Market Size, 2018-2029
6.4.3 France Respiratory Disorders Drugs Market Size, 2018-2029
6.4.4 U.K. Respiratory Disorders Drugs Market Size, 2018-2029
6.4.5 Italy Respiratory Disorders Drugs Market Size, 2018-2029
6.4.6 Russia Respiratory Disorders Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Respiratory Disorders Drugs Market Size, 2018-2029
6.4.8 Benelux Respiratory Disorders Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Respiratory Disorders Drugs Revenue, 2018-2029
6.5.2 China Respiratory Disorders Drugs Market Size, 2018-2029
6.5.3 Japan Respiratory Disorders Drugs Market Size, 2018-2029
6.5.4 South Korea Respiratory Disorders Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Respiratory Disorders Drugs Market Size, 2018-2029
6.5.6 India Respiratory Disorders Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Respiratory Disorders Drugs Revenue, 2018-2029
6.6.2 Brazil Respiratory Disorders Drugs Market Size, 2018-2029
6.6.3 Argentina Respiratory Disorders Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Respiratory Disorders Drugs Revenue, 2018-2029
6.7.2 Turkey Respiratory Disorders Drugs Market Size, 2018-2029
6.7.3 Israel Respiratory Disorders Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Respiratory Disorders Drugs Market Size, 2018-2029
6.7.5 UAE Respiratory Disorders Drugs Market Size, 2018-2029
7 Respiratory Disorders Drugs Companies Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Respiratory Disorders Drugs Major Product Offerings
7.1.4 Novartis Respiratory Disorders Drugs Revenue in Global Market (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Sanofi
7.2.1 Sanofi Company Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Respiratory Disorders Drugs Major Product Offerings
7.2.4 Sanofi Respiratory Disorders Drugs Revenue in Global Market (2018-2023)
7.2.5 Sanofi Key News & Latest Developments
7.3 Teva Pharmaceutical
7.3.1 Teva Pharmaceutical Company Summary
7.3.2 Teva Pharmaceutical Business Overview
7.3.3 Teva Pharmaceutical Respiratory Disorders Drugs Major Product Offerings
7.3.4 Teva Pharmaceutical Respiratory Disorders Drugs Revenue in Global Market (2018-2023)
7.3.5 Teva Pharmaceutical Key News & Latest Developments
7.4 Merck & Co.
7.4.1 Merck & Co. Company Summary
7.4.2 Merck & Co. Business Overview
7.4.3 Merck & Co. Respiratory Disorders Drugs Major Product Offerings
7.4.4 Merck & Co. Respiratory Disorders Drugs Revenue in Global Market (2018-2023)
7.4.5 Merck & Co. Key News & Latest Developments
7.5 Sumitomo Dainippon Pharma
7.5.1 Sumitomo Dainippon Pharma Company Summary
7.5.2 Sumitomo Dainippon Pharma Business Overview
7.5.3 Sumitomo Dainippon Pharma Respiratory Disorders Drugs Major Product Offerings
7.5.4 Sumitomo Dainippon Pharma Respiratory Disorders Drugs Revenue in Global Market (2018-2023)
7.5.5 Sumitomo Dainippon Pharma Key News & Latest Developments
7.6 Mylan
7.6.1 Mylan Company Summary
7.6.2 Mylan Business Overview
7.6.3 Mylan Respiratory Disorders Drugs Major Product Offerings
7.6.4 Mylan Respiratory Disorders Drugs Revenue in Global Market (2018-2023)
7.6.5 Mylan Key News & Latest Developments
7.7 AstraZeneca
7.7.1 AstraZeneca Company Summary
7.7.2 AstraZeneca Business Overview
7.7.3 AstraZeneca Respiratory Disorders Drugs Major Product Offerings
7.7.4 AstraZeneca Respiratory Disorders Drugs Revenue in Global Market (2018-2023)
7.7.5 AstraZeneca Key News & Latest Developments
7.8 Boehringer Ingelheim International
7.8.1 Boehringer Ingelheim International Company Summary
7.8.2 Boehringer Ingelheim International Business Overview
7.8.3 Boehringer Ingelheim International Respiratory Disorders Drugs Major Product Offerings
7.8.4 Boehringer Ingelheim International Respiratory Disorders Drugs Revenue in Global Market (2018-2023)
7.8.5 Boehringer Ingelheim International Key News & Latest Developments
7.9 Vertex Pharmaceuticals Incorporated
7.9.1 Vertex Pharmaceuticals Incorporated Company Summary
7.9.2 Vertex Pharmaceuticals Incorporated Business Overview
7.9.3 Vertex Pharmaceuticals Incorporated Respiratory Disorders Drugs Major Product Offerings
7.9.4 Vertex Pharmaceuticals Incorporated Respiratory Disorders Drugs Revenue in Global Market (2018-2023)
7.9.5 Vertex Pharmaceuticals Incorporated Key News & Latest Developments
7.10 Roche
7.10.1 Roche Company Summary
7.10.2 Roche Business Overview
7.10.3 Roche Respiratory Disorders Drugs Major Product Offerings
7.10.4 Roche Respiratory Disorders Drugs Revenue in Global Market (2018-2023)
7.10.5 Roche Key News & Latest Developments
7.11 GlaxoSmithKline
7.11.1 GlaxoSmithKline Company Summary
7.11.2 GlaxoSmithKline Business Overview
7.11.3 GlaxoSmithKline Respiratory Disorders Drugs Major Product Offerings
7.11.4 GlaxoSmithKline Respiratory Disorders Drugs Revenue in Global Market (2018-2023)
7.11.5 GlaxoSmithKline Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Respiratory Disorders Drugs Market Opportunities & Trends in Global Market
Table 2. Respiratory Disorders Drugs Market Drivers in Global Market
Table 3. Respiratory Disorders Drugs Market Restraints in Global Market
Table 4. Key Players of Respiratory Disorders Drugs in Global Market
Table 5. Top Respiratory Disorders Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Respiratory Disorders Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Respiratory Disorders Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Respiratory Disorders Drugs Product Type
Table 9. List of Global Tier 1 Respiratory Disorders Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Respiratory Disorders Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Respiratory Disorders Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Respiratory Disorders Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Respiratory Disorders Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Respiratory Disorders Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Respiratory Disorders Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Respiratory Disorders Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Respiratory Disorders Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Respiratory Disorders Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Respiratory Disorders Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Respiratory Disorders Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Respiratory Disorders Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Respiratory Disorders Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Respiratory Disorders Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Respiratory Disorders Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Respiratory Disorders Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Respiratory Disorders Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Respiratory Disorders Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Respiratory Disorders Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Respiratory Disorders Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Novartis Company Summary
Table 31. Novartis Respiratory Disorders Drugs Product Offerings
Table 32. Novartis Respiratory Disorders Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis Key News & Latest Developments
Table 34. Sanofi Company Summary
Table 35. Sanofi Respiratory Disorders Drugs Product Offerings
Table 36. Sanofi Respiratory Disorders Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Sanofi Key News & Latest Developments
Table 38. Teva Pharmaceutical Company Summary
Table 39. Teva Pharmaceutical Respiratory Disorders Drugs Product Offerings
Table 40. Teva Pharmaceutical Respiratory Disorders Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Teva Pharmaceutical Key News & Latest Developments
Table 42. Merck & Co. Company Summary
Table 43. Merck & Co. Respiratory Disorders Drugs Product Offerings
Table 44. Merck & Co. Respiratory Disorders Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Merck & Co. Key News & Latest Developments
Table 46. Sumitomo Dainippon Pharma Company Summary
Table 47. Sumitomo Dainippon Pharma Respiratory Disorders Drugs Product Offerings
Table 48. Sumitomo Dainippon Pharma Respiratory Disorders Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Sumitomo Dainippon Pharma Key News & Latest Developments
Table 50. Mylan Company Summary
Table 51. Mylan Respiratory Disorders Drugs Product Offerings
Table 52. Mylan Respiratory Disorders Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Mylan Key News & Latest Developments
Table 54. AstraZeneca Company Summary
Table 55. AstraZeneca Respiratory Disorders Drugs Product Offerings
Table 56. AstraZeneca Respiratory Disorders Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. AstraZeneca Key News & Latest Developments
Table 58. Boehringer Ingelheim International Company Summary
Table 59. Boehringer Ingelheim International Respiratory Disorders Drugs Product Offerings
Table 60. Boehringer Ingelheim International Respiratory Disorders Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Boehringer Ingelheim International Key News & Latest Developments
Table 62. Vertex Pharmaceuticals Incorporated Company Summary
Table 63. Vertex Pharmaceuticals Incorporated Respiratory Disorders Drugs Product Offerings
Table 64. Vertex Pharmaceuticals Incorporated Respiratory Disorders Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Vertex Pharmaceuticals Incorporated Key News & Latest Developments
Table 66. Roche Company Summary
Table 67. Roche Respiratory Disorders Drugs Product Offerings
Table 68. Roche Respiratory Disorders Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Roche Key News & Latest Developments
Table 70. GlaxoSmithKline Company Summary
Table 71. GlaxoSmithKline Respiratory Disorders Drugs Product Offerings
Table 72. GlaxoSmithKline Respiratory Disorders Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. GlaxoSmithKline Key News & Latest Developments
List of Figures
Figure 1. Respiratory Disorders Drugs Segment by Type in 2022
Figure 2. Respiratory Disorders Drugs Segment by Application in 2022
Figure 3. Global Respiratory Disorders Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Respiratory Disorders Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Respiratory Disorders Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Respiratory Disorders Drugs Revenue in 2022
Figure 8. By Type - Global Respiratory Disorders Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Respiratory Disorders Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Respiratory Disorders Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Respiratory Disorders Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Respiratory Disorders Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Respiratory Disorders Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Respiratory Disorders Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Respiratory Disorders Drugs Revenue Market Share, 2018-2029
Figure 16. US Respiratory Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Respiratory Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Respiratory Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Respiratory Disorders Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Respiratory Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Respiratory Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Respiratory Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Respiratory Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Respiratory Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Respiratory Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Respiratory Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Respiratory Disorders Drugs Revenue Market Share, 2018-2029
Figure 28. China Respiratory Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Respiratory Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Respiratory Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Respiratory Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Respiratory Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Respiratory Disorders Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Respiratory Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Respiratory Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Respiratory Disorders Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Respiratory Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Respiratory Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Respiratory Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Respiratory Disorders Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Novartis Respiratory Disorders Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Sanofi Respiratory Disorders Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Teva Pharmaceutical Respiratory Disorders Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Merck & Co. Respiratory Disorders Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Sumitomo Dainippon Pharma Respiratory Disorders Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Mylan Respiratory Disorders Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. AstraZeneca Respiratory Disorders Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Boehringer Ingelheim International Respiratory Disorders Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Vertex Pharmaceuticals Incorporated Respiratory Disorders Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Roche Respiratory Disorders Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. GlaxoSmithKline Respiratory Disorders Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
